Olyth
Home
About
Terms
Privacy
60 Degrees Pharmaceuticals, Inc (SXTPW) Stock Price, Chart & News | Olyth
SXTPW
60 Degrees Pharmaceuticals, Inc
$0.04
+$0.04 (+0.00%)
Today
Chart data unavailable
Key Statistics
Market cap
—
Price-Earnings ratio
—
Dividend yield
—
Average volume
—
High today
$0.04
Low today
$0.03
Open price
$0.05
Volume
—
52 Week high
$0.04
52 Week low
$0.03
Company Profile
Recent News
Recent News
GlobeNewswire
6/11/2026
60 Degrees Pharmaceuticals Signs Exclusive Patent License Agreement with Florida State University for Non-Prescription Use of Australian Chestnut Extract as a Botanical Supplement
MT Newswires
6/11/2026
60 Degrees Pharmaceuticals Licenses Patent to Produce Australian Chestnut Extract
GlobeNewswire
5/26/2026
60 Degrees Pharmaceuticals Announces Early Enrollment of First Seasonal Patient in Clinical Trial of Tafenoquine for Patients Hospitalized with Babesiosis
GlobeNewswire
5/15/2026
60 Degrees Pharmaceuticals Announces First Quarter 2026 Results
GlobeNewswire
4/15/2026
60 Degrees Pharma Announces ARAKODA (tafenoquine) for Malaria Prevention is Now Available on Runway Health Travel Website
GlobeNewswire
3/31/2026
60 Degrees Pharmaceuticals Announces 2025 Annual Results
ACCESS Newswire
4/20/2026
RedChip's Biotech Investor Conference Replays Now Available
Zacks
4/3/2026
60 Degrees Pharmaceuticals Inc. (SXTP) Upgraded to Buy: Here's What You Should Know
Company Profile
No profile description available.